*Krankenhaus*

Vienna 01090

0 studies enrolling now · 1 studies all time

What they study most

Follicular Lymphoma, Marginal Zone Lymphoma

Studies at this site

• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling